Public Profile

Harrow, Inc.

Harrow, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States and operates primarily in the specialty pharmaceuticals sector. Founded in 2013, the company has made significant strides in developing innovative treatments, particularly in the areas of ophthalmology and other niche therapeutic markets. Harrow's core offerings include a range of proprietary prescription eye medications, distinguished by their unique formulations and delivery methods. The company has established a strong market position, recognised for its commitment to improving patient outcomes through advanced drug development. With a focus on quality and efficacy, Harrow continues to achieve notable milestones, solidifying its reputation as a trusted name in specialty pharmaceuticals.

DitchCarbon Score

How does Harrow, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Harrow, Inc.'s score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Harrow, Inc.'s reported carbon emissions

Harrow, Inc., headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that Harrow, Inc. has not outlined any specific reduction targets or commitments to climate initiatives. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have formalised its climate commitments within the industry context. As the global focus on sustainability intensifies, it will be crucial for Harrow, Inc. to establish clear emissions reduction goals and engage in climate action to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Harrow, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Harrow, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Harrow, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ocular Therapeutix, Inc.

US
Health and social work services (85)
Updated 3 days ago

Allergan

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Omeros Corporation

US
Health and social work services (85)
Updated 3 days ago

Diplomat Pharmacy, Inc.

US
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 3 months ago
DitchCarbon Score

Janssen

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Neoleukin Therapeutics, Inc.

US
Health and social work services (85)
Updated about 2 months ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers